First Foundation Advisors lowered its holdings in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 47.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,050 shares of the technology company's stock after selling 16,000 shares during the period. First Foundation Advisors' holdings in Koninklijke Philips were worth $458,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the business. Choreo LLC boosted its stake in shares of Koninklijke Philips by 4.6% during the 1st quarter. Choreo LLC now owns 14,530 shares of the technology company's stock worth $369,000 after acquiring an additional 633 shares in the last quarter. Allworth Financial LP boosted its stake in shares of Koninklijke Philips by 16.2% during the 1st quarter. Allworth Financial LP now owns 4,638 shares of the technology company's stock worth $115,000 after acquiring an additional 645 shares in the last quarter. GeoWealth Management LLC boosted its stake in shares of Koninklijke Philips by 4.5% during the 4th quarter. GeoWealth Management LLC now owns 19,255 shares of the technology company's stock worth $488,000 after acquiring an additional 825 shares in the last quarter. Assetmark Inc. boosted its stake in shares of Koninklijke Philips by 1.7% during the 1st quarter. Assetmark Inc. now owns 59,806 shares of the technology company's stock worth $1,519,000 after acquiring an additional 982 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in shares of Koninklijke Philips by 1.1% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 100,140 shares of the technology company's stock worth $2,544,000 after acquiring an additional 1,137 shares in the last quarter. Institutional investors own 13.67% of the company's stock.
Koninklijke Philips Stock Up 1.0%
Shares of PHG traded up $0.26 during mid-day trading on Friday, reaching $26.46. The company's stock had a trading volume of 1,781,655 shares, compared to its average volume of 1,215,315. The business has a fifty day moving average of $24.03 and a 200 day moving average of $24.98. The company has a market cap of $25.48 billion, a price-to-earnings ratio of 139.26, a price-to-earnings-growth ratio of 0.72 and a beta of 0.76. Koninklijke Philips N.V. has a 1 year low of $21.48 and a 1 year high of $32.91. The company has a quick ratio of 0.79, a current ratio of 1.26 and a debt-to-equity ratio of 0.69.
Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.29 by $0.12. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. The business had revenue of $5.05 billion for the quarter, compared to analysts' expectations of $4.35 billion. As a group, analysts forecast that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen lowered Koninklijke Philips from a "buy" rating to a "hold" rating in a research note on Saturday. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy".
Read Our Latest Stock Analysis on PHG
Koninklijke Philips Profile
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Read More

Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.